{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "37820706",
  "DateCompleted": {
    "Year": "2023",
    "Month": "11",
    "Day": "01"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "11",
    "Day": "01"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2023",
        "Month": "10",
        "Day": "01"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.3928/19382359-20230829-03"
    ],
    "Journal": {
      "ISSN": "1938-2359",
      "JournalIssue": {
        "Volume": "52",
        "Issue": "10",
        "PubDate": {
          "Year": "2023",
          "Month": "Oct"
        }
      },
      "Title": "Pediatric annals",
      "ISOAbbreviation": "Pediatr Ann"
    },
    "ArticleTitle": "Febrile Seizures.",
    "Pagination": {
      "StartPage": "e388",
      "EndPage": "e393",
      "MedlinePgn": "e388-e393"
    },
    "Abstract": {
      "AbstractText": [
        "Febrile seizures (FSs) are the most common cause of pediatric seizures. They are defined as seizures in children age 6 months to 5 years with a temperature higher than 100.4\u00b0F, although they are more common at higher temperatures. A family history of FS is the most common risk factor. FSs are classified into three types (simple, complex, or febrile status epilepticus) based on duration and quality, with simple FSs accounting for many cases. Most FSs persist for less than 10 minutes and are self-limiting. Approximately one-third of patients will have recurrence of FSs. Safe and effective prophylaxis for FS has yet to be identified. Most patients will not have any long-term sequelae, although there is an increased risk of epilepsy, particularly for those with febrile status epilepticus. FSs are associated with caregiver anxiety, \"fever phobia,\" and high health care use, emphasizing the importance of education and reassurance for both the provider and family. <b>[<i>Pediatr Ann</i>. 2023;52(10):e388-e393.]</b>."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Biltz",
        "ForeName": "Samantha",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Speltz",
        "ForeName": "Laura",
        "Initials": "L"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Pediatr Ann",
    "NlmUniqueID": "0356657",
    "ISSNLinking": "0090-4481"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Child"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Infant"
    },
    {
      "QualifierName": [
        "diagnosis",
        "etiology",
        "therapy"
      ],
      "DescriptorName": "Seizures, Febrile"
    },
    {
      "QualifierName": [
        "diagnosis",
        "etiology"
      ],
      "DescriptorName": "Fever"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Epilepsy"
    },
    {
      "QualifierName": [
        "complications"
      ],
      "DescriptorName": "Status Epilepticus"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk Factors"
    }
  ]
}